
Martin 'Pharma Bro' Shkreli's reputation precedes him
The latest on the fraud trial of Martin "Pharma Bro" Shkreli.
The latest on the fraud trial of Martin "Pharma Bro" Shkreli.
Researchers call for urgent action over an antipsychotic drug linked to 13 NZ deaths.
NZ scientists have made a surprise genetic finding that could help combat drug resistance.
The world's next big antibiotic could lie hidden in our native fungi.
Doctors are on the cusp of launching the first new male contraceptive.
Like many people, Deborah Hill Cone admired Jono Pryor's courage in sharing his feelings.
AFT Pharmaceuticals raised new funds through a redeemable share issue to fuel international growth.
AFT Pharmaceuticals expects annual sales to meet analysts' forecasts of about $70 million.
Doctors have expressed concern that the changes could undermine the relationship between women and their GPs.
Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion.
Pharmac announced today it would start funding the breast cancer drug Perjeta, but 160 Kiwis who have already started treatment won't be eligible.
AFT Pharmaceuticals widened its first-half loss after ramping up R&D and launching over-the-counter products in Australia and Singapore.
Kiwi experts are on the front lines fighting the "antibiotic apocalypse".
A major medical marijuana trial is underway in New Zealand - testing the effects of a new cannabis gel on epilepsy patients.
As a nationwide opioid epidemic raged, DEA investigators went after companies distributing millions of highly addictive pills. Then, their cases ground to a halt.
Douglas Pharmaceuticals expects the US market to become its biggest, overtaking the EU in the near future.
NZ Cancer Society medical director Dr Christopher Jackson discusses urgent worries around New Zealand's systems for reviewing and funding ground-breaking new cancer drugs.
Weaning animals from antibiotics in favor of vaccines has become central as resistant superbugs become more prevalent in public spaces.
The Auckland-based drug developer posted a $8.9 million operating loss for the year to March 31.
He plays the blues and is credited with figuring out how drug companies can justify hiking prices charged to vulnerable patients.
The New Zealand branch of the pharmaceutical giant Pfizer sent tens of millions offshore while paying virtually no tax.
Trade Minister Todd McClay says he sees no reason why big pharmaceutical firms would stop supplying new medicines in New Zealand.
No argument against the proposed TPP packs more emotional punch than the claim that the deal would be bad for people's health.
The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.
The botox boom is hitting China - where it's the young, not the old getting the jab.
Viagra could be given to women in childbirth to reduce complications and save babies' lives.
Notorious pharmaceuticals businessman Martin Shkreli has offered Kanye West $10 million to buy his album -- but there's a catch -- he doesn't want it released publicly.
Australia's federal government has introduced draft laws allowing the cultivation and supply of marijuana for medicinal or scientific purposes.
Martin Shkreli is being sued by an artist who says his work was used on the Wu-Tang Clan album Shkreli paid $2 million for.
'Pharma-bro' Martin Shkreli has started a Twitter feud with Wu-Tang Clan.